The largest database of trusted experimental protocols

Cathepsin b

Manufactured by R&D Systems
Sourced in Japan, United States

Cathepsin B is a lysosomal cysteine protease that plays a role in various physiological and pathological processes. It is involved in protein degradation and processing, and has been implicated in conditions such as cancer, inflammation, and neurodegeneration. Cathepsin B is commonly used as a research tool to study these processes.

Automatically generated - may contain errors

14 protocols using cathepsin b

1

Fab Degradation by Cathepsin B and S

Check if the same lab product or an alternative is used in the 5 most similar protocols
CZP and CZNP were incubated with Cathepsin B (R&D System, Minneapolis, Minnesota) or Cathepsin S (R&D System Minneapolis, Minnesota) with a 10:1 molar ratio (Fab 2µM: Cathepsin 0,2 µM) in the appropriate digestion buffer at varying times at 37° C. Cathepsin B digestion buffer: MES pH5 25mM, 50µM DTT. Cathepsin S digestion buffer: NaOAc 50 mM pH 4.5, 250mM NaCl, 50µM DTT. Cathepsin B and S were activated in the appropriate buffer with 1mM DTT before dilution and use. Reaction was stopped by addition of 5x Laemmli buffer and stored at 4°C before SDS-PAGE analysis. Degradation of Fab was assessed in SDS-PAGE after silver staining of the gels.
+ Open protocol
+ Expand
2

Targeted Protease Antibody Labeling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies toward targeted proteases (cathepsin B, cathepsin L, legumain and human neutrophil elastase) were purchased from R&D Systems. Antibody labeling with stable metal isotopes was performed according to protocol described elsewhere (https://web.stanford.edu/group/nolan/protocols.html). All necessary reagents were purchased from Fluidigm®.
+ Open protocol
+ Expand
3

Pseudovirus Proteolytic Activation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The proteases used were resuspended according to each of the manufacturer’s protocols: trypsin-TPCK (tosylsulfonyl phenylalanyl chloromethyl ketone) (Sigma), cathepsin L (R&D Systems), cathepsin B (R&D Systems), soluble TMPRSS2 (Abnova), human airway trypsin-like protease (R&D Systems). For each experiment, labeled pseudovirus was diluted 10-fold in HB with the designated protease concentration and incubated at 37°C for 1 h. The mixture was then diluted in 200 μL HB and added to a microfluidic flow cell channel at a rate of 20 μL/min while the video was recorded as described below.
+ Open protocol
+ Expand
4

Cathepsin Inhibitors and Viral Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
GCDCA and chloroquine were purchased from Sigma-Aldrich (St Louis, MO). Cathepsin L inhibitors, Z-FY-CHO and MDL28170, were purchased from Santa Cruz Biotech (Santa Cruz, CA), and a cathepsin B inhibitor CA074-Me was purchased from Sigma-Aldrich. Recombinant human cathepsin L and cathepsin B were purchased from R & D systems (Minneapolis, MN). The primary antibodies used in this study were anti-PEC/Cowden antibodies raised in swine (Chang et al., 2005 (link)), anti-PEC VP2 antibodies raised in guinea pig (Chang et al., 2005 (link)), anti-FCV antibodies raised in guinea pig (Sosnovtsev and Green, 1995 (link)), anti-MNV-1 antibodies raised in guinea pig (Wobus et al., 2004 (link)) and anti-Rab7 antibodies (Santa Cruz Biotech, CA). The secondary antibodies for Western blot analysis included horseradish peroxidase-conjugates of anti-swine Ig and anti-guinea pig Ig antibody (Thermo Scientific, Pittsburgh, PA). The secondary antibodies for confocal microscopy were FITC-labeled anti-swine IgG for PEC (Kirkegaard & Perry Lab Inc, MD), FITC-labeled anti-guinea pig IgG for MNV-1 (Sigma-Aldrich, MO) and anti-rabbit PerCP-Cy 5.5 (Santa Cruz Biotech, CA). Other basic chemicals for confocal microscopy and other studies were purchased from various sources including Sigma-Aldrich.
+ Open protocol
+ Expand
5

Antibody Sources for Western Blot

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary antibodies were obtained from the following sources: Na+/K+ ATPase‐α, calnexin, calpain 2, CDK2, cyclin B1, cyclin E, ERK2, lamin B, HA tag, p21, p27Kip1, p57Kip2, β‐tubulin from Santa Cruz Biotechnology (Santa Cruz, CA), β‐actin from Chemicon International (Billerica, MA), phospho‐AKT (Ser473), AKT, phosphorylated ERK1/2 (T202/Y204), and Lamp1 from Cell Signaling Technology (Danvers, MA) and Cathepsin B from R&D Systems (Mississauga, ON, Canada). Mouse and rabbit horseradish peroxidase antibodies were purchased from Amersham Biosciences (Pittsburg, PA), goat horseradish peroxidase antibody from Santa Cruz, and alkaline phosphatase‐conjugated antibodies were purchased from Promega (Madison, WI).
+ Open protocol
+ Expand
6

Comprehensive Protein Analysis in Neurobiology

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antibodies against the following proteins were used in Western blot and immunohistochemical and immunocytochemical analysis: β-Actin (Merck; #A5441); Calbindin (Swant; #300); Cathepsin B (R&D Systems; #AF965); CerS5 (Invitrogen; #PA5-20569); CerS6 (Santa Cruz; #sc100554); EEA1 (R&D Systems; #MAB8047); F4/80 (Abcam; #ab6640); GAPDH (Abcam; #ab8245); GFAP (Merck; # MAB3402); GM130 (BD; #610823); Iba1 (Wako; #019-19741); Lamp1 (DSHB; #1D4B); LSDP5 (Abcam; #ab222811); MAP2 (Biolegend; #822501); PSD95 (Neuromab; #75-028); TOM20 (Santa Cruz; #sc-11415).
+ Open protocol
+ Expand
7

Granzyme B Activation and Inhibition Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Pro-granzyme B (R&D Systems) was activated to granzyme B using cathepsin B (R&D systems) following the manufacturer’s protocol. Enzyme activity was assessed by cleavage of BOC-Ala-Ala-Asp-SBZL (Sigma) and reaction with DTNB (Sigma) with absorbance measurements at 405 nm (NanoDrop 2000 Spectrophotometer, Thermo Scientific). Serial dilutions of non-radioactive gallium-labeled NOTA-GZP were used to inhibit granzyme B by incubation at 37°C for 30 min prior to addition of substrate. Additionally, 68Ga-NOTA-GZP was incubated with the activated forms of granzyme B, granzyme A (R&D Systems), granzyme H (R&D Systems), granzyme K (Enzo Life Sciences) and pro-granzyme B to assess the specificity of the peptide. After a 30 min incubation at 37°C, enzymes were purified by size exclusion chromatography and bound radioactivity assessed by gamma counter (Wizard 2480, Perkin Elmer).
+ Open protocol
+ Expand
8

Protein Analysis in Neurodegenerative Disorders

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary antibodies for western blotting were VPS13C (HPA043507, 1:500; Sigma-Aldrich, 28676-1-AP, 1:800; Proteintech), phosphoRab10-T73 (230261, 1:500; Abcam), Rab10 (8127, 1:1,000; Cell Signaling), βIII-Tubulin (4466S, 1:4,000; Biolegend), TH (657012, 1:2,000; Millipore), GAPDH (2,118, 1:2,000; Millipore), α-Tubulin (5168, 1:20,000; Sigma-Aldrich), LAMP2 (H4B4, 1:1,000; DSHB), GCase (G4171, 1:1,000; Sigma-Aldrich), Rab7 (137029, 1:1,000; Abcam), HA (3724, 1:2,000; Cell Signaling), Calnexin (1:1,000; Cell Signaling), TOM20 (612278, 1:1,000; BD Biosciences), PEX5 (83020S, 1:500, Cell Signaling), GFP (1544, 1:2,000; Sigma-Aldrich), Myc (2278, 1:2,000; Cell Signaling), cathepsin B (AF953, 1:2,000; R&D systems), cathepsin D (6487, 1:1,000; Santa Cruz), LRRK2 (ab133474, 1:500; Abcam), LRRK2-S935 (ab133450, 1:500; Abcam), EHBP1 (17637-1-AP, 1:1,000; Proteintech), and PPM1H (PA5-26102, 1:1,000; Invitrogen).
Primary antibodies for immunofluorescence were βIII-Tubulin (4466S, 1:300; Biolegends), TH (657012, 1:300; Millipore), and LAMP1 (sc-20011, 1:300; Santa Cruz).
Primary antibodies for PLA were VPS13C (28676-1-AP, 1:100; Proteintech) and Rab10 (ab104859, 1:100; Abcam).
+ Open protocol
+ Expand
9

Quantitative Protein Analysis by Western Blot

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole cell lysates were prepared as described for quantitative proteome comparison. Cell lysates were centrifuged at 15000 g for 2 min, and protein concentration in the supernatant was determined with a bicinchoninic acid protein assay (BCA, Pierce). Equal amounts of protein extracts (5 to 40 μg depending on the antibody used) were resolved by SDS-PAGE and transferred onto polyvinylidene fluoride (PVDF) membranes using a semi-dry blotting system (Bio-Rad, Hercules, CA, USA). For immune detection of proteins, membranes were probed with the following antibodies: DJ-1 (R&D Systems 3668, Minneapolis, MN, USA), GAP43 (Böhringer 1379011, Ingelheim, Germany), β3-Tubulin (Sigma T8660, Kavasaki, Japan), Cathepsin B (R&D Systems AF953), methylglyoxal (MGO, Cell Biolabs Inc. STA-011, San Diego, CA, USA). β-Tubulin (Sigma Aldrich T6199) or GAPDH (abcam 9484) were used as loading control. methylglyoxal (MGO) immunoblots were stripped by incubating the membrane with pre-heated stripping buffer (2% SDS, 62.5 mM Tris-HCl pH 6.8, 1:125 v/v ß-mercaptoethanol) at 50 °C for 45 min, followed by rinsing for 1–2 h with water and 5 min with TBST before they were blocked and re-probed with GAPDH antibody. Signal intensity was analyzed with ImageJ [38 (link)].
+ Open protocol
+ Expand
10

Cathepsin B Purification and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
All reported measurements in this study used purified recombinant human cathepsin B containing proenzyme (∼60%) and mature (∼40%) cathepsin B, purchased from R&D Systems Inc. (Minneapolis, MN, USA). The molecular weights are 37 and 25 kDa, respectively, predicted from the sequence. Thus the average molecular weight of ∼33.8 kDa was used in all concentration calculations. Only a few control experiments in immunoprecipitation study used cathepsin B purchased from Santa Cruz Biotechnology Inc. (Dallas, TX, USA). In normal activity measurements, cathepsin B and the breast cell lysates were activated for 15 min in 5 mM dithiothreitol (DTT) and 25 mM 2-(4-morpholino)ethanesulfonic acid (MES) buffer (pH 5.0) to convert the proenzyme into the active form. The details of other reagents are listed in the Supplementary Information (SI). The synthesis of cathepsin B specific tetrapeptide H2N-(CH2)4-CO-Leu-Arg-Phe-Gly-NH-CH2-Fc and other peptides including tripeptide Arg-Phe-Gly-NH-CH2-Fc, dipeptide Phe-Gly-NH-CH2-Fc and modified single amino acid Gly-NH-CH2-Fc for studying cleaving sites is also described in the SI (Scheme S1). The cathepsin B inhibitor GC-373 was prepared17 (link) in house as described in the SI.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!